Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. It is believed to be the hepatic manifestation of the metabolic syndrome. Many treatment approaches have been suggested so far, and several types of studies have been done to find treatment for NAFLD, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Teshome, Getnet, Ambachew, Sintayehu, Fasil, Alebachew, Abebe, Molla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522518/
https://www.ncbi.nlm.nih.gov/pubmed/33061687
http://dx.doi.org/10.2147/HMER.S265631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522518/
https://www.ncbi.nlm.nih.gov/pubmed/33061687
http://dx.doi.org/10.2147/HMER.S265631

Ejemplares similares